242 related articles for article (PubMed ID: 19344240)
1. Treatment of chronic hepatitis B: focus on telbivudine.
Lui YY; Chan HL
Expert Rev Anti Infect Ther; 2009 Apr; 7(3):259-68. PubMed ID: 19344240
[TBL] [Abstract][Full Text] [Related]
2. Telbivudine: a novel nucleoside analog for chronic hepatitis B.
Kim JW; Park SH; Louie SG
Ann Pharmacother; 2006 Mar; 40(3):472-8. PubMed ID: 16507625
[TBL] [Abstract][Full Text] [Related]
3. A review of telbivudine for the management of chronic hepatitis B virus infection.
Lui YY; Chan HL
Expert Opin Drug Metab Toxicol; 2008 Oct; 4(10):1351-61. PubMed ID: 18798704
[TBL] [Abstract][Full Text] [Related]
4. Telbivudine in the treatment of chronic hepatitis B.
Nash K
Adv Ther; 2009 Feb; 26(2):155-69. PubMed ID: 19225726
[TBL] [Abstract][Full Text] [Related]
5. Telbivudine: an effective anti-HBV drug for chronic hepatitis B patients with early on-treatment responses.
Hann HW
Expert Opin Pharmacother; 2010 Sep; 11(13):2243-9. PubMed ID: 20698726
[TBL] [Abstract][Full Text] [Related]
6. 2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B.
Liaw YF; Gane E; Leung N; Zeuzem S; Wang Y; Lai CL; Heathcote EJ; Manns M; Bzowej N; Niu J; Han SH; Hwang SG; Cakaloglu Y; Tong MJ; Papatheodoridis G; Chen Y; Brown NA; Albanis E; Galil K; Naoumov NV;
Gastroenterology; 2009 Feb; 136(2):486-95. PubMed ID: 19027013
[TBL] [Abstract][Full Text] [Related]
7. Safety evaluation of telbivudine.
But DY; Yuen MF; Fung J; Lai CL
Expert Opin Drug Saf; 2010 Sep; 9(5):821-9. PubMed ID: 20662545
[TBL] [Abstract][Full Text] [Related]
8. Telbivudine versus lamivudine in patients with chronic hepatitis B.
Lai CL; Gane E; Liaw YF; Hsu CW; Thongsawat S; Wang Y; Chen Y; Heathcote EJ; Rasenack J; Bzowej N; Naoumov NV; Di Bisceglie AM; Zeuzem S; Moon YM; Goodman Z; Chao G; Constance BF; Brown NA;
N Engl J Med; 2007 Dec; 357(25):2576-88. PubMed ID: 18094378
[TBL] [Abstract][Full Text] [Related]
9. [Telbivudine in the treatment of the chronic B hepatitis].
ButĂ MA
Gastroenterol Hepatol; 2008 Apr; 31(4):258-63. PubMed ID: 18405491
[No Abstract] [Full Text] [Related]
10. Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial.
Hou J; Yin YK; Xu D; Tan D; Niu J; Zhou X; Wang Y; Zhu L; He Y; Ren H; Wan M; Chen C; Wu S; Chen Y; Xu J; Wang Q; Wei L; Chao G; Constance BF; Harb G; Brown NA; Jia J
Hepatology; 2008 Feb; 47(2):447-54. PubMed ID: 18080339
[TBL] [Abstract][Full Text] [Related]
11. Telbivudine for the management of chronic hepatitis B virus infection.
Matthews SJ
Clin Ther; 2007 Dec; 29(12):2635-53. PubMed ID: 18201580
[TBL] [Abstract][Full Text] [Related]
12. [The efficacy and safety of telbivudine in korean patients with chronic hepatitis B].
Moon YM; Hwang SG; Kim BS; Rim KS; Cho M; Kim DJ; Han JY; Kim YS; Choi HS; Ahn SH
Korean J Hepatol; 2007 Dec; 13(4):503-12. PubMed ID: 18159148
[TBL] [Abstract][Full Text] [Related]
13. A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients.
Zheng MH; Shi KQ; Dai ZJ; Ye C; Chen YP
Clin Ther; 2010 Apr; 32(4):649-58. PubMed ID: 20435234
[TBL] [Abstract][Full Text] [Related]
14. [The efficacy of nucleoside/nucleotide analogue on chronic hepatitis B].
Lin Q; Zhang DZ
Zhonghua Gan Zang Bing Za Zhi; 2009 Oct; 17(10):722-5. PubMed ID: 19874684
[No Abstract] [Full Text] [Related]
15. Chronic hepatitis B: who to treat and which choice of treatment?
Di Marco V; Craxì A
Expert Rev Anti Infect Ther; 2009 Apr; 7(3):281-91. PubMed ID: 19344242
[TBL] [Abstract][Full Text] [Related]
16. A dose-finding study of once-daily oral telbivudine in HBeAg-positive patients with chronic hepatitis B virus infection.
Lai CL; Lim SG; Brown NA; Zhou XJ; Lloyd DM; Lee YM; Yuen MF; Chao GC; Myers MW
Hepatology; 2004 Sep; 40(3):719-26. PubMed ID: 15349912
[TBL] [Abstract][Full Text] [Related]
17. Drug profile: telbivudine (Tyzeka).
Pham PA; Thio C
Hopkins HIV Rep; 2007 Jan; 19(1):7, 10. PubMed ID: 17569169
[No Abstract] [Full Text] [Related]
18. Telbivudine: an upcoming agent for chronic hepatitis B.
Yuen MF; Lai CL
Expert Rev Anti Infect Ther; 2005 Aug; 3(4):489-94. PubMed ID: 16107194
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of telbivudine following oral administration of escalating single and multiple doses in patients with chronic hepatitis B virus infection: pharmacodynamic implications.
Zhou XJ; Lim SG; Lloyd DM; Chao GC; Brown NA; Lai CL
Antimicrob Agents Chemother; 2006 Mar; 50(3):874-9. PubMed ID: 16495245
[TBL] [Abstract][Full Text] [Related]
20. Telbivudine.
Dienstag J; Easley C; Kirkpatrick P
Nat Rev Drug Discov; 2007 Apr; 6(4):267-8. PubMed ID: 17458000
[No Abstract] [Full Text] [Related]
[Next] [New Search]